Evidence map›Paper›PMID 32711042›Full record

ArticleThe Journal of infection2020

Influenza-like illness is associated with high pneumococcal carriage density in Malawian children.

Tinashe K Nyazika, Alice Law, Todd D Swarthout, Lusako Sibale, Danielle Ter Braake, Neil French, Robert S Heyderman, Dean Everett, Aras Kadioglu, Kondwani C Jambo and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Intracellular survival ofFrontiers in immunology · 2022
    Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Tinashe K NyazikaMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; Department of Pathology, College of Health Sciences, University of Malawi, Blantyre, Malawi. Electronic address: tknyazika@mlw.mw.
Alice LawInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Todd D SwarthoutMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi; Division of Infection and Immunity, NIHR Global Health Research Unit on Mucosal Pathogens, University College London, London, United Kingdom.
Lusako SibaleMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Danielle Ter BraakeInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom; Department of Biomolecular Health Sciences, Division of Infectious Diseases & Immunology, Faculty of Veterinary Medicine, Utrecht, the Netherlands.
Neil FrenchInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Robert S HeydermanDivision of Infection and Immunity, NIHR Global Health Research Unit on Mucosal Pathogens, University College London, London, United Kingdom.
Dean EverettThe Queens Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Aras KadiogluInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Kondwani C JamboMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom. Electronic address: kjambo@mlw.mw.
Daniel R NeillInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
University of Liverpool · GBUniversity of Malawi · MWMalawi-Liverpool-Wellcome Trust Clinical Research Programme · MWUniversity College London · GBUniversity of Edinburgh · GBUtrecht University · NL

Funding

Department of HealthMedical Research Council MR/P011284/1NCEZID CDC HHS U01 CK000146Wellcome TrustWellcome Trust 101113/Z/13/Z084Wellcome Trust 105831/Z/14/ZWellcome Trust 204457/Z/16/Z
6 · The paper itself

Abstract

backgroundHigh pneumococcal carriage density is a risk factor for invasive pneumococcal disease (IPD) and transmission, but factors that increase pneumococcal carriage density are still unclear.

methodsWe undertook a cross-sectional study to evaluate the microbial composition, cytokine levels and pneumococcal carriage densities in samples from children presenting with an influenza-like illness (ILI) and asymptomatic healthy controls (HC).

resultsThe proportion of children harbouring viral organisms (Relative risk (RR) 1.4, p = 0.0222) or ≥ 4 microbes at a time (RR 1.9, p < 0.0001), was higher in ILI patients than HC. ILI patients had higher IL-8 levels in nasal aspirates than HC (median [IQR], 265.7 [0 - 452.3] vs. 0 [0 - 127.3] pg/ml; p = 0.0154). Having an ILI was associated with higher pneumococcal carriage densities compared to HC (RR 4.2, p < 0.0001).

conclusionThese findings suggest that children with an ILI have an increased propensity for high pneumococcal carriage density. This could in part contribute to increased susceptibility to IPD and transmission in the community.

Indexed as

Influenza, HumanPneumococcal InfectionsCarrier StateChildCross-Sectional StudiesHumansInfantNasopharynxPneumococcal VaccinesRisk FactorsStreptococcus pneumoniaePneumococcal VaccinesCarriage densityChildrenIL-8Influenza-like illnessPneumococcal

Identifiers

PMID32711042
PMCPMC7375306
OpenAlexW3045011468

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.